Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist

Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist

US Patent 8153160 · Granted Apr 10, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cardiopulmonary disorders2024
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof2022
Amine substituted triazole derivatives and uses thereof2022
Prodrugs of substituted triazole derivatives and uses thereof2022
Substituted triazole derivatives and uses thereof2022
Substituted triazole derivatives and uses thereof2021
Substituted triazole derivatives and uses thereof2021
Amide-substituted pyridinyltriazole derivatives and uses thereof2021
Substituted piperidinyl tetrahydroquinolines2021
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof2021
Amide-substituted phenyltriazole derivatives and uses thereof2020
Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereof2020